ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,035,590 | +10.1% | 267,360 | +4.9% | 0.03% | +15.4% |
| Q2 2023 | $22,736,884 | -10.2% | 254,755 | +7.9% | 0.03% | -16.1% |
| Q1 2023 | $25,324,721 | +5.6% | 236,194 | +20.3% | 0.03% | +3.3% |
| Q4 2022 | $23,974,119 | +77.5% | 196,300 | +49.2% | 0.03% | +76.5% |
| Q3 2022 | $13,505,000 | +35.8% | 131,600 | +23.0% | 0.02% | +41.7% |
| Q2 2022 | $9,944,000 | -25.5% | 106,971 | -6.0% | 0.01% | 0.0% |
| Q1 2022 | $13,355,000 | -11.0% | 113,791 | +2.0% | 0.01% | -7.7% |
| Q4 2021 | $15,011,000 | +3.9% | 111,583 | +23.1% | 0.01% | -13.3% |
| Q3 2021 | $14,446,000 | +59.1% | 90,635 | +18.0% | 0.02% | +66.7% |
| Q2 2021 | $9,079,000 | -32.9% | 76,821 | -26.8% | 0.01% | -40.0% |
| Q1 2021 | $13,532,000 | -36.0% | 104,995 | -17.2% | 0.02% | -42.3% |
| Q4 2020 | $21,145,000 | +18.4% | 126,781 | +9.5% | 0.03% | +4.0% |
| Q3 2020 | $17,865,000 | +1.3% | 115,765 | -2.9% | 0.02% | 0.0% |
| Q2 2020 | $17,630,000 | +36.8% | 119,205 | +4.2% | 0.02% | +13.6% |
| Q1 2020 | $12,883,000 | -24.2% | 114,404 | -6.4% | 0.02% | -12.0% |
| Q4 2019 | $17,001,000 | +38.8% | 122,204 | -3.9% | 0.02% | +31.6% |
| Q3 2019 | $12,252,000 | -7.0% | 127,204 | +11.2% | 0.02% | -5.0% |
| Q2 2019 | $13,169,000 | +28.1% | 114,368 | +30.9% | 0.02% | +25.0% |
| Q1 2019 | $10,283,000 | +114.1% | 87,368 | +14.0% | 0.02% | +100.0% |
| Q4 2018 | $4,804,000 | +2.4% | 76,672 | +15.8% | 0.01% | +14.3% |
| Q3 2018 | $4,693,000 | +20.7% | 66,236 | +13.3% | 0.01% | +16.7% |
| Q2 2018 | $3,887,000 | +14.0% | 58,436 | +12.1% | 0.01% | +20.0% |
| Q1 2018 | $3,410,000 | +341.1% | 52,136 | +170.1% | 0.01% | +400.0% |
| Q4 2017 | $773,000 | – | 19,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |